Studies
The CTN+ supports clinical trials to find new ways to prevent, treat and manage HIV and other STBBIs, prioritizing a community-based approach of the highest scientific and ethical standards.
-
CTN 214: Effect of a one-year course of HAART in acute/early HIV
A randomized trial of highly active antiretroviral therapy in acute/early HIV infection
-
CTN 198: Supportive therapy for adherence with antiretroviral treatment
STAART The purpose of this study was to determine whether a psycho-educational intervention can help people living with HIV handle the challenges of treatment adherence. The study examined the impact of a particular psycho-educational intervention, titled Supportive Therapy for Adherence to Antiretroviral Treatment (STAART), on readiness for treatment, treatment knowledge, coping with side effects, treatment…
-
CTN 194: Peg-interferon and citalopram in co-infection (PICCO)
Trial of Citalopram for the Prevention of Depression
-
CTN 237: Influenza vaccination strategies using Fluviral in HIV-positive adults
Immunogenicity and efficacy study of Fluviral® influenza vaccine strategies in HIV infected Adults: Trial results
-
CTN 227: Hepatitis C therapeutic vaccine
Open label, dose escalating phase I/II study of TG4040 (MVA-HCV) in patients chronically infected with hepatitis C virus (Genotype I) who relapsed from previous pegylated interferon/ribavirin treatment
-
CTN 221: NGX-4010 for the treatment of painful HIV-associated neuropathy
A multicenter randomized, double-blind, controlled study of NGX-4010 for the treatment of painful HIV-associated neuropathy: Trial results
-
CTN 203: Phase I/II study of Remune® plus Amplivax™
A Phase I/II safety and immunogencity study of a combination of whole-killed HIV-1 antigen and Amplivax, administered with or without IFA, in HIV-1 infected Participants: Trial results
-
CTN 190: Strategies for management of ART (The SMART Study)
A Comparison of Two Ways to Manage Anti-HIV Treatment
-
CTN 173: Vaccination before treatment interruption
A pilot study to determine the impact of therapeutic HIV vaccination followed by a scheduled interruption of antiretroviral therapy on HIV-specific immune function and virologic rebound in patients with prolonged viral suppression: Trial results
-
CTN 167: Options with antiretrovirals (OPTIMA)
A tri-national (Canada, UK, USA) randomized, controlled trial to determine the optimal management of patients with HIV infection for whom first and second-line highly active antiretroviral therapy has failed
-
CTN 164: Treatment Interruption
A Prospective Randomized Trial of Structured Treatment Interruption (STI) Followed by the Initiation of a New Antiretroviral Regimen vs. Immediate Switching to a New Antiretroviral Regimen in HIV-Infected Patients Experiencing Virologic Failure on HAART
Careers
Interested in joining our team? Here are the current career opportunities with the CTN+ and our collaborators. For Fellowship opportunities, please visit our Postdoctoral Fellowship program page.
Learn More